• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 41 of 100
Michael Bloomberg Drug Pricing Patents
Health
Michael Bloomberg’s radical plan to cut prescription drug costs
By Sy MukherjeeJanuary 28, 2020
Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud Trial
Health
‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law
By Erik Larson, Riley Griffin and BloombergJanuary 27, 2020
China Coronavirus Vaccine
Newsletters
The hunt for a coronavirus vaccine begins
By Sy MukherjeeJanuary 24, 2020
Civica Rx Blue Cross Generic Drug Prices
Health
Major insurers are teaming up with a nonprofit to cut the price of generic drugs
By Sy MukherjeeJanuary 23, 2020
FDA Sarepta Drug Approval Controversy
Newsletters
Does the FDA need to slow its drug approval roll?
By Sy MukherjeeJanuary 22, 2020
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
Magazine
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
By Jennifer AlseverJanuary 20, 2020
JPM 2020
Newsletters
Biopharma’s big week is upon us
By Sy MukherjeeJanuary 13, 2020
FDA Drug Approvals 2019
Newsletters
The FDA Kept Up Its Drug Approval Streak In 2019
By Sy MukherjeeJanuary 7, 2020
A heart graphic is seen displayed on an Apple Watch in this photo illustration in Warsaw, Poland on April 25, 2019.
Commentary
Pharma needs to stop chasing shiny objects and start embracing practical technology
By Paul HudsonJanuary 7, 2020
Big-Pharma-Prescription-Drugs
Health
Big Pharma Raised Prices of Several Prescription Drugs on First Day of 2020
By Chris MorrisJanuary 2, 2020
Sarepta Stock Roche Deal
Health
Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
By Sy MukherjeeDecember 23, 2019
Big Pharma ROI
Newsletters
Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low
By Sy MukherjeeDecember 18, 2019
Multiple myeloma MMRF
Newsletters
GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug
By Sy MukherjeeDecember 17, 2019
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
Health
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
By David Eggert and The Associated PressDecember 17, 2019
Drugs and Tech Revolutionizinf Healthcare
Health
The 4 Most Game-Changing Medical Advances of the Past Decade
By Sy MukherjeeDecember 17, 2019
1...
  • 39
  • 40
  • 41
  • 42
  • 43
...100
Most Popular
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Politics
Tesla and 113 other companies paid no current federal income tax, but they still aren’t the biggest threats to the federal deficit, think tank warnsplaceholder alt text
By Sasha RogelbergOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.